Urocanic acid (UCA) is a major epidermal chromophore that undergoes trans to cis isomerization after ultraviolet radiation (UVR). cis-UCA suppresses cell-mediated immunity. Recent studies suggest that cis-UCA binds to serotonin (5-hydroxytryptamine) 2A (5-HT 2A ) receptor and that antagonists of 5-HT 2A and the plateletactivating factor (PAF) receptor can block cis-UCA-induced immune suppression in mice. Here, we examined the involvement of 5-HT 2A and PAF receptors in the ability of cis-UCA to stimulate immunomodulatory mediator production in primary human keratinocytes. Using real-time reverse transcription-PCR (RT-PCR), PAF but not 5-HT 2A receptor mRNA was constitutively expressed in primary human keratinocytes. Treatment with cis-UCA increased prostaglandin E 2 (PGE 2 ), tumor necrosis factor-a (TNF-a), and IL-6 secretion, whereas 5-HT only stimulated IL-6 production. Pretreatment with a 5-HT receptor antagonist partially inhibited IL-6 increase by 5-HT, but did not inhibit mediator production by cis-UCA. Similarly, a PAF receptor antagonist did not inhibit cis-UCA-induced increase in PGE 2 . Intracellular calcium mobilization studies using a human epithelial cell line stably transfected with PAF receptor also showed little evidence that cis-UCA stimulated PAF receptor and it did not bind to this receptor. Thus, cis-UCA stimulates mediator production by a pathway that is independent of these receptors in human keratinocytes, and these cells may not be the major target for cis-UCA-induced immune suppression.
INTRODUCTION
Exposure to solar ultravoilet radiation (UVR) (B295 to 400 nm) suppresses cell-mediated immunity in healthy humans (Kelly et al., 2000) . The data from animal models have shown that UVR-induced immune suppression plays an important role in photocarcinogenesis and immunity to pathogens allowing tumor cells/pathogens to evade immune surveillance and persist in the host (Fisher and Kripke, 1977; Termorshuizen et al., 2002) . A similar role is suspected in humans, yet the role of UVR-induced immune suppression in humans is not fully understood (Termorshuizen et al., 2002; Norval, 2006) .
The molecular mechanisms underlying UVR-induced immune suppression are complex and unclear, but absorption of UV photons by epidermal chromophores (photoreceptors) is required to initiate the biological response. Urocanic acid (UCA), a deamination product of histidine, is a major epidermal chromophore and present as trans-isomer in the stratum corneum. Upon absorption of UVR, trans-UCA undergoes a photoisomerization to its cis-isomer. There is considerable evidence that topical or systemic application of cis-UCA but not trans-UCA can suppress cell-mediated immunity and mimic many of the immunomodulatory effects of UVR in mice (Gibbs et al., 2008) .
It has long been hypothesized that the effects of cis-UCA are mediated through a membrane receptor. Although a specific keratinocyte receptor for cis-UCA has not yet been identified, Walterscheid et al. (2006) have recently reported that cis-UCA may act through the serotonin (5-hydroxytryptamine) 2A (5-HT 2A ) receptor because of structural similarities between cis-UCA and 5-HT. They showed that cis-UCA competitively binds to the 5-HT 2A receptor and activates cells through the 5-HT 2A receptor by measuring intracellular calcium mobilization in a human 5-HT 2A receptor overexpressing in vitro model system. In addition, a 5-HT 2A receptor antagonist inhibited cis-UCA-induced suppression of the delayed-type hypersensitivity response in mice.
Besides cis-UCA, the production of the lipid mediator of inflammation, platelet-activating factor (PAF), is an early event in UVR-induced immunosuppression. PAF and its analogs are secreted by epidermal cells in response to the oxidative stress induced by UVR (Calignano et al., 1988; Barber et al., 1998) and exert effects through the PAF receptor expressed in various cell types, including monocytes, mast cells, and keratinocytes (Simon et al., 1994; Travers et al., 1995; Nilsson et al., 2000) . Studies in mice have shown that PAF receptor antagonists inhibit UVR-induced immune suppression. A cyclooxygenase-2 (COX-2) inhibitor and an IL-10-neutralizing antibody block the PAF-induced reduction in delayed-type hypersensitivity and contact hypersensitivity responses, suggesting that PAF initiates a cytokine cascade through prostaglandin E 2 (PGE 2 ) release that leads to immune suppression (Walterscheid et al., 2002; Zhang et al., 2008) . Interestingly, Walterscheid et al. have shown that a PAF receptor antagonist as well as a 5-HT 2A receptor antagonist inhibit cis-UCA-induced suppression of the delayed-type hypersensitivity response in mice. In addition, either antagonist can inhibit photocarcinogenesis in mice (Sreevidya et al., 2008) .
The mechanism of action of cis-UCA is still poorly understood. As the photoisomerization to cis-UCA takes place in the epidermis, keratinocytes may be a potential target for cis-UCA. We have shown earlier that, in primary human keratinocytes, cis-UCA upregulates UVR-inducible genes including COX-2, resulting in increased production of immunomodulatory mediators such as PGE 2 , tumor necrosis factor-a (TNF-a), and IL-6 (Kaneko et al., 2008) . The release of PGE 2 from keratinocytes has been suggested as initiating IL-4 and then IL-10 production in serum, thus leading to systemic immune suppression (Shreedhar et al., 1998) . IL-4 is unlikely to be secreted by keratinocytes (Shreedhar et al., 1998) , and it is debatable whether human keratinocytes produce IL-10 after UVR exposure (Jackson et al., 1996; Teunissen et al., 1997) . We were also unable to detect either IL-4 or IL-10 protein in keratinocytes after UCA or UVR treatment. In addition, the immunosuppressive effects of cis-UCA may be partially mediated by TNF-a, as anti-TNF-a-treated mice show a reduced cis-UCA-induced suppression of the contact hypersensitivity response (Kurimoto and Streilein, 1992) .
The aim of this study was to determine whether the 5-HT 2A and PAF receptors are involved in the ability of cis-UCA to stimulate the production of PGE 2 , TNF-a, and IL-6 in primary human keratinocytes.
RESULTS

Keratinocytes express PAF but not 5-HT 2A receptor mRNA
First, we assessed the expression of 5-HT 2A and PAF receptor mRNAs in primary human keratinocytes derived from three donors ( Figure 1) . Unexpectedly, 5-HT 2A receptor mRNA was not detected, but PAF receptor mRNA was constitutively expressed in keratinocytes. We analyzed further eight primary human keratinocyte lines for 5-HT 2A receptor mRNA, but it was not detected (data not shown). In contrast, both 5-HT 2A and PAF receptor mRNAs were detected in primary human fibroblasts ( Figure 1 ). cis-UCA induces PGE 2 and cytokine release that are not inhibited by the 5-HT receptor antagonist, Metergoline 5-HT receptors are classified into seven distinct families including at least 14 subtypes (Barnes and Sharp, 1999) . To examine the involvement of any 5-HT receptors in cis-UCAmediated production of immunomodulatory mediators, primary human keratinocytes were treated with cis-UCA (70 or 700 mM) or 5-HT (0.1 or 1 mM) for 24 hours, and their effects on PGE 2 and cytokine production were compared. As shown in Figure 2 , treatment with 700 mM cis-UCA increased PGE 2 , IL-6, and TNF-a secretion into the cell culture supernatant after 24 hours. In contrast, 1 mM 5-HT stimulated only IL-6 production and had no effect on PGE 2 and TNF-a secretion. Similar trends were observed at a lower concentration (data not shown). In addition, the pretreatment with Metergoline, an antagonist of 5-HT 1 , 5-HT 2 , and 5-HT 7 receptors (Martin and Sanders-Bush, 1982; Bard et al., 1993; Audinot et al., 1997) , had no inhibitory effect on cis-UCAmediated PGE 2 or cytokine production, although the IL-6 increase by 5-HT was partially but significantly inhibited ( Figure 2 ). The results suggest that cis-UCA induces mediator production independently of 5-HT receptor signaling pathways.
cis-UCA is unlikely to stimulate and does not bind to the PAF receptor in the PAF-receptor-transfected human epithelial cells
Having confirmed that primary human keratinocytes constitutively express the PAF receptor, we firstly carried out calcium mobilization studies using the KB PAF receptor model system to evaluate the ability of cis-UCA to stimulate the PAF receptor. The human epithelial KB cell line does not express functional PAF receptor (Pei et al., 1998) . The results are given in Figure 3a . PAF caused a transient intracellular Ca 2 þ flux in PAF-receptor-transfected KBP cells, but had no effect on vector-only-transfected PAFreceptor-negative KBM cells. Treatment with cis-UCA also resulted in a weak and delayed Ca 2 þ flux in KBP cells, which was considered insignificant, and had no effect in KBM cells. Treatment with trans-UCA did not alter intracellular Ca 2 þ levels in either KBP or KBM cells. In addition, no calcium flux was observed in either KBP or KBM cells when the cells were treated with 5-HT (data not shown). To determine whether cis-UCA might bind to the PAF receptor, KBP cells were treated with [ 3 H]WEB2086, a radiolabeled PAF receptor antagonist, with or without cis-UCA or trans-UCA, or PAF at 4 1C to quantify the displacement of [ 3 H]WEB2086 from the PAF receptor. As shown in Figure 3b , the addition of 1 mM PAF resulted in a significant decrease in [ 3 H]WEB2086 binding to the PAF receptor. In contrast, neither cis-UCA nor trans-UCA up to 500 mM could compete with [ 3 H]WEB2086 for binding to the PAF receptor, suggesting that cis-UCA can stimulate the PAF receptor without direct binding to it.
cis-UCA has minimal effects on PAF-receptor-mediated PGE 2 production Both cis-UCA and PAF induce COX-2 and increase PGE 2 release (Pei et al., 1998; Kaneko et al., 2008) . We further examined whether cis-UCA enhances PGE 2 production through the PAF receptor. As shown in Figure 3c , PAF significantly enhanced PGE 2 secretion into the cell culture supernatant only in PAF-receptor-positive KBP cells but not in KBM cells. cis-UCA tended to increase PGE 2 release in both KBP and KBM cells, although the increase was significant only at 700 mM in the KBP cells, and no significant difference was seen in the increase between KBM and KBP cells. trans-UCA had no effect on PGE 2 release in either cells.
To confirm the results obtained in the KB PAF receptor model system, primary human keratinocytes were pretreated with 10 mM of ABT-491, a PAF receptor antagonist (Albert et al., 1997) , for 1 hour before treatment with cis-UCA or PAF for 24 hours. As shown in Figure 4 , the pretreatment with ABT-491 almost completely blocked the PAF-induced increase in PGE 2 release, but had no inhibitory effect on the PGE 2 increase by cis-UCA. Taken together, the results suggest that the involvement of the PAF receptor in cis-UCAinduced PGE 2 production is minimal.
DISCUSSION
The release of immunomodulatory mediators is an important event in the initiation of UVR-induced immune suppression.
In this study, we tested the hypothesis that cis-UCA increases PGE 2 and cytokine production through 5-HT 2A and/or PAF receptor in primary human keratinocytes. Our results suggest that cis-UCA stimulates the production of these mediators by a pathway that is independent of these receptors in primary human keratinocytes. Slominski et al. (2003) have reported that primary human epidermal keratinocytes and dermal fibroblasts express 5-HT 1A , 5-HT 1B , 5-HT 2A , 5-HT 2B , and 5-HT 7 receptor mRNAs. However, we did not detect 5-HT 2A receptor mRNA in 11 primary human keratinocyte lines (Figure 1) , neither could we detect the mRNA expression of 5-HT 2A receptor in the same cell lines 6 hours after exposure to a physiologically relevant dose (12 J cm À2 ) of solar-simulated UVR (data not shown). This was the case despite using a quantitative TaqMan real-time reverse transcriptase-PCR (RT-PCR) with a specific TaqMan probe, which is more sensitive than the earlier authors' qualitative gel-based RT-PCR method. The TaqMan probe and primers we used were designed across an exon-exon boundary that ensures that the signal is generated only from RNA, whereas the primers used by Slominski et al.
were designed within single exon that may have amplified genomic DNA.
There are no reports on the role of 5-HT receptor signaling on mediator production in keratinocytes, but it has been shown that 5-HT modulates cytokine and PGE 2 release through 5-HT 1 , 5-HT 2 , 5-HT 3 , 5-HT 4 , and/or 5-HT 7 receptors in other cell types, including human airway epithelial cells, monocytes, and dendritic cells (Cloez-Tayarani et al., 2003; Idzko et al., 2004; Durk et al., 2005; Bayer et al., 2007) . Our results indicated that 5-HT stimulated IL-6 release mediated through 5-HT 1 , 5-HT 2 , and/or 5-HT 7 receptors, but had no effect on PGE 2 or TNF-a release in primary human keratinocytes (Figure 2) . cis-UCA also increased IL-6 release, an effect not inhibited by a 5-HT receptor antagonist, indicating that 5-HT and cis-UCA stimulate IL-6 release by different mechanisms in human keratinocytes. However, Reeve et al. (2009) have reported that suppression of the contact hypersensitivity response by cis-UCA was not altered in the IL-6À/À mice, suggesting that IL-6 is unlikely to be involved in cis-UCA-induced immune suppression. Unlike 5-HT, cis-UCA enhanced PGE 2 and TNF-a release, and neither of these was blocked by a 5-HT receptor antagonist.
Consistent with our results, Woodward et al. (2006) also suggest that cis-UCA does not regulate immunomodulatory mediator production through the 5-HT 2A receptor, although their test system involved human peripheral blood mononuclear cells rather than keratinocytes. Human peripheral blood mononuclear cells have been reported to express 5-HT 1A , 5-HT 1B , 5-HT 1E , 5-HT 2A , 5-HT 3 , 5-HT 4 , and 5-HT 6 receptors (Yang et al., 2006) . Woodward et al. showed that cis-UCA increased PGE 2 release in a dose-dependent manner, but a supraphysiological concentration of 5-HT was required to induce the same level of PGE 2 . Similarly, both cis-UCA and 5-HT suppressed lipopolysaccharide- induced TNF-a production. However, indomethacin, a COX inhibitor, completely abrogated the suppression by cis-UCA, whereas significant suppression by 5-HT remained in the presence of indomethacin. Although the studies relied on the in vitro response to cis-UCA and thus may not necessarily reflect in vivo situations, there is a possibility that other receptor signaling pathways are involved in the production of immunomodulatory mediators by cis-UCA in humans. Expression of the PAF receptor in keratinocytes has been reported (Travers et al., 1995) and we also detected the PAF receptor. Using the KB PAF receptor model, we did not obtain convincing evidence that cis-UCA stimulated the PAF receptor (Figure 3) . The delay in the onset of the calcium response to cis-UCA suggests that cis-UCA could induce its effects on intracellular Ca 2 þ levels in KBP cells by the generation of endogenous PAF agonists as has been shown for staphylococcal alpha-toxin (Travers et al., 2003) . As mentioned in the Introduction section, PAF is synthesized in response to stress induced by various stimuli including UVR (Calignano et al., 1988; Barber et al., 1998; Alappatt et al., 2000) . Our earlier study showed that cis-UCA causes oxidative stress (Kaneko et al., 2008) , and also Steenvoorden and Beijersbergen van (1999) reported that topical treatment with antioxidants inhibited cis-UCA-induced local immune suppression in mice, suggesting that cis-UCA may stimulate the PAF receptor as a result of a stress response. However, our results showed that cis-UCA had only minimal effects on PGE 2 production through the PAF receptor. Neither overexpression of the PAF receptor nor a PAF receptor antagonist affected the increase in PGE 2 release induced by cis-UCA (Figures 3c and 4) . It is concluded that PAF receptor signaling is not the main pathway by which cis-UCA induces PGE 2 synthesis in human keratinocytes.
The data published by Walterscheid et al. (2006) showed that cis-UCA activates the 5-HT 2A receptor in an in vitro model system, but did not provide evidence to conclude that cis-UCA exerts its effects through direct binding to the 5-HT 2A receptor in vivo. They reported that an antibody against 5-HT blocked suppression of the delayed-type hypersensitivity response by cis-UCA in mice. This implies that the 5-HT antibody captures cis-UCA and blocks the binding of cis-UCA to specific receptors. The cell type or types involved and their location were not identified. Matsumura et al. (2006) have reported that inhibition of both PAF and 5-HT 2A receptor binding is necessary to block UVRinduced immune suppression, and Sreevidya et al. (2008) found that PAF and 5-HT 2A receptor antagonists act in a synergistic manner to prevent UVR-induced skin tumors. These results indicate that 5-HT 2A and PAF receptors are closely related to each other in UVR-induced immune suppression. There is considerable evidence that PAF induces 5-HT release from platelets, which are a major source of skin 5-HT (Kravis and Henson, 1975; Chesney et al., 1982; Bailey et al., 2000; Nordlind et al., 2008) . For the activation of platelets, only picomolar levels of PAF are required. Although our data did not confirm that cis-UCA enhances mediator production through the PAF receptor in keratinocytes, cis-UCA stimulation of the PAF receptor may be strong enough to induce release of 5-HT from platelets, which then binds to the 5-HT 2A receptor possibly in mast cells and T cells, resulting in immune suppression. Whether cis-UCA stimulates 5-HT release remains to be seen. Walterscheid et al. (2006) speculate that cis-UCA may bind to mast cells, thus stimulating them to release PAF. However, studies in rat and mouse peritoneal cells have shown that PAF is released from macrophages, not from mast cells, and that PAF production is unrelated to 5-HT release by activation of mast cells (Mencia-Huerta and Benveniste, 1979; Pellon et al., 1993) . Thus, PAF release through 5-HT receptor is less likely to happen.
Keratinocytes are a major source of cytokines in the skin, and an important candidate for the site of action of cis-UCA. Our findings suggest that there is a 5-HT 2A receptorindependent pathway for cis-UCA in human keratinocytes. Further study is required to elucidate its identity but activation of epidermal growth factor receptor may be involved, as it is a well-established mechanism by which UVR-induced reactive oxygen species lead to COX-2 expression and subsequent PGE 2 production (Rundhaug and Fischer, 2008) . However, Zhang et al. (2008) report that, in mice, immunomodulatory mediators from bone marrowderived dendritic cells and monocytes play a more important role in UVR-induced immune suppression than those from keratinocytes. It is possible that keratinocytes may not be the primary target for cis-UCA-induced immune suppression, and the role of 5-HT 2A and PAF receptors in other cell types in the skin remains to be determined.
MATERIALS AND METHODS
Cells
Primary cultures of epidermal keratinocytes were prepared from biopsies taken from the unexposed buttock skin of healthy Caucasian volunteers (for receptor mRNA expression) or from the face or from the abdominal skin of healthy Caucasian donors who had undergone cosmetic surgery (for cytokine and PGE 2 release) as described earlier (Kaneko et al., 2008) . There was no difference in the effects of cis-UCA between the keratinocytes from the different sites. Keratinocytes were grown in serum-free keratinocyte medium supplemented with 50 mg ml À1 pituitary extract, 2.5 ng ml À1 epidermal growth factor, 100 U ml À1 penicillin, and 100 mg ml À1 streptomycin (Invitrogen, Paisley, UK) and were used in experiments at the third passage. Primary cultures of dermal fibroblasts were prepared from biopsies taken from the unexposed buttock skin of healthy Caucasian volunteers. Briefly, the dermis separated from epidermal sheets was cut into pieces and placed into six-well plates to grow fibroblasts in DMEM supplemented with 10% fetal bovine serum, 2 mM L-glutamine, 100 U ml À1 penicillin, and 100 mg ml À1 streptomycin (Invitrogen). The procedure was approved by St Thomas' Hospital Ethics Committee, adhering to the Declaration of Helsinki Principles, and the donors gave written informed consent. Human epithelial KB cell lines stably transfected with the human PAF receptor (designated as KBP cells) or with control MSCV2.1 retrovirus (designated as KBM cells), prepared as described earlier (Pei et al., 1998) , were grown in DMEM supplemented with 10% fetal bovine serum, 2 mM L-glutamine, 50 U ml À1 penicillin, 50 mg ml À1 www.jidonline.org 2571 K Kaneko et al.
streptomycin, 1% minimum essential medium non-essential amino acids, and 1% minimum essential medium vitamins solution (Invitrogen). All cells were maintained at 37 1C in 5% CO 2 , and the medium was changed every 2-3 days. For all experiments, cells were fed 24 hours before treatment and allowed to grow to 80% confluency.
Reagents
All chemicals were obtained from Sigma-Aldrich Company Ltd. (Dorset, UK), unless otherwise indicated. cis-UCA was prepared from trans-UCA as described earlier and was 499% pure as determined by HPLC (Norval et al., 1989) . UCA isomers and 5-HT were dissolved in phosphate-buffered saline (PBS) and PBS served as a baseline control. PAF and Metergoline were dissolved in ethanol and ABT-491 was dissolved in deionized water.
TaqMan real-time RT-PCR
Total RNA was extracted from primary human keratinocytes and fibroblasts using RNA-Bee (Tel-Test, Friendswood, TX), and cDNA was generated from total RNA of each sample using TaqMan Reverse Transcription Reagents (Applied Biosystems, Foster City, CA) following the manufacturer's instructions. The expression level of mRNA was analyzed by TaqMan real-time RT-PCR on an ABI Prism 7700 Sequence Detection System (Applied Biosystems) with the following TaqMan probes: 5-HT 2A receptor, Hs00167241_m1 and PAF receptor, Hs00265392_s1, as provided by the manufacturer. Glyceraldehyde-3-phosphate dehydrogenase served as an endogenous control gene.
Intracellular calcium mobilization
KB cells were loaded with Ca 2 þ -sensitive dye Fura-2 AM (Invitrogen) and treated with PAF (100 nM), or with trans-UCA or cis-UCA (140 mM). Intracellular Ca 2 þ flux was measured as described earlier (Travers et al., 1995) .
Radioligand binding assays
Displacement of 10 nM [ 3 H]WEB2086 (New England Nuclear Corp, Boston, MA) radioligand binding to the PAF receptor by PAF (1 mM), or by trans-UCA or cis-UCA (50-500 mM) was analyzed as described earlier (Pei et al., 1998) .
Cytokines and PGE 2 measurements
Supernatants were collected 24 hours after treatment with trans-UCA or cis-UCA, with 5-HT, or with PAF by centrifugation. TNF-a, IL-6, and PGE 2 concentrations were measured using DuoSet ELISA kits (R&D Systems Europe, Abingdon, UK) and a Parameter PGE 2 Assay (R&D Systems Europe) according to the manufacturer's instructions.
Statistical analysis
Student's unpaired t-test was carried out using SPSS 11.5 software (SPSS Inc., Chicago, IL). Values of Po0.05 were considered significant.
